PPV as a proportion of prostate cancer among biopsied individuals ranged from 35.3% to 42.0%, and ratio between screen-detected cancer and PSA-positive varied from 9.6% to 13.9%. The gene discussed is KLK3; the disease is prostate carcinoma.